MacroGenics | MGNX - Ebitda

Stock Price
3.19
Daily Change
0.01 0.31%
Monthly
0.63%
Yearly
86.55%
Q2 Forecast
3.12

MacroGenics reported $21.95M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
Amgen USD 5.14B 775M Dec/2025
AstraZeneca USD 5.23B 272M Sep/2025
Biogen USD 573.2M 253.7M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Daiichi Sankyo JPY 101.6B 22.81B Mar/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Genmab DKK 186M 291M Dec/2025
Geron USD -9.47M 1.92M Sep/2025
Gilead Sciences USD 3.02B 1.01B Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
MacroGenics USD 21.95M 55.39M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Puma Biotechnology USD 729K 11.36M Jun/2024
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Xencor USD -51.05M 55.28M Dec/2025